Journey Medical
(NASDAQ) DERM
Journey Medical Financials at a Glance
Market Cap
$220.49M
Revenue (TTM)
$59.40M
Net Income (TTM)
$8.66M
EPS (TTM)
$-0.37
P/E Ratio
-18.06
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Price
$6.63
Volume
3,544
Open
$7.11
Price
$6.63
Volume
3,544
Open
$7.11
Previous Close
$6.63
Daily Range
$6.63 - $7.18
52-Week Range
$5.51 - $9.55
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Price
$6.63
Volume
3,544
Open
$7.11
Previous Close
$6.63
Daily Range
$6.63 - $7.18
52-Week Range
$5.51 - $9.55
DERM News
DERM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Journey Medical
Industry
Pharmaceuticals
Sector
Health CareEmployees
41
CEO
Claude Maraoui
Website
www.journeymedicalcorp.comHeadquarters
Scottsdale, AZ 85258, US
DERM Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
-9%
Net Income Margin
-15%
Return on Equity
-47%
Return on Capital
-12%
Return on Assets
-10%
Earnings Yield
-5.54%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$220.49M
Shares Outstanding
33.26M
Volume
3.54K
Short Interest
0.00%
Avg. Volume
138.40K
Financials (TTM)
Gross Profit
$35.26M
Operating Income
$13.68M
EBITDA
$8.40M
Operating Cash Flow
$9.13M
Capital Expenditure
$15.00M
Free Cash Flow
$9.13M
Cash & ST Invst.
$20.30M
Total Debt
$25.70M
Journey Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$17.63M
+20.5%
Gross Profit
$11.88M
+27.1%
Gross Margin
67.36%
N/A
Market Cap
$220.49M
N/A
Market Cap/Employee
$5.38M
N/A
Employees
41
N/A
Net Income
$2.31M
+3.1%
EBITDA
$314.00K
+60.5%
Quarterly Fundamentals
Net Cash
$353.00K
-113.4%
Accounts Receivable
$17.98M
+68.5%
Inventory
$11.82M
+0.3%
Long Term Debt
$19.58M
-1.0%
Short Term Debt
$5.72M
+16732.4%
Return on Assets
-10.17%
N/A
Return on Invested Capital
-12.08%
N/A
Free Cash Flow
$2.38M
-106.0%
Operating Cash Flow
$2.38M
-106.0%